Skip to main content
logo
Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
13.06
+0.49 (3.90%)
At close: Nov 6, 2026, 4:00 PM EST
13.36
+0.30 (2.30%)
Pre-market: Nov 9, 2026, 8:55 AM EST

Generate Biomedicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Market Capitalization
1,676--
Market Cap Growth
---
Enterprise Value
1,281--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.140.360.22
Net Debt / Equity Ratio
-0.87-0.81-0.89
Net Debt / EBITDA Ratio
1.580.691.74
Net Debt / FCF Ratio
1.620.752.61
Asset Turnover
-0.08-
Quick Ratio
8.082.704.55
Current Ratio
8.302.854.70
Return on Equity (ROE)
--81.72%-
Return on Assets (ROA)
--34.63%-
Return on Capital Employed (ROCE)
-52.00%-94.80%-45.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
--2.77%-
SEC Filings: 10-K · 10-Q